Acelity

San Antonio, United States Founded: 1976 • Age: 50 yrs Acquired By 3M
Wound therapeutics and regenerative medicine products are developed globally.

About Acelity

Acelity is a Healthcare company based in San Antonio (United States) founded in 1976, and was acquired by 3M in May 2019. Wound therapeutics and regenerative medicine products are developed globally. Acelity has completed 2 acquisitions, including Crawford Healthcare and Systagenix. Its Indian entity Kci Medical India Private Limited reported revenue of ₹136 Cr. Its focus areas include Diversified Medical Devices.

Company details

Acelity is a privately held globally diversified medical device company. It is a non-operating holding company whose wholly owned subsidiaries develop wound therapeutics and regenerative medicine products. The advanced wound therapeutics business is conducted by Kinetic Concepts and its subsidiaries, including Systagenix, and the regenerative medicine business is conducted by LifeCell. Acelitys products are sold in over 80 countries. Its Advanced wound therapeutics unit produces products including negative pressure wound therapy, negative pressure surgical incision management, and epidermal harvesting. Its Regenerative medicine unit produces products encompassing regenerative and reconstructive acellular tissue matrices for repair of soft tissue defects, as well as autologous fat grafting solutions. Acelity began as Kinetic Concepts Inc., a medical technology company founded in 1976. In October 2013, KCI acquired Systagenix Wound Management, originally Johnson Johnsons professional wound care business for 485 million. In September 2014, KCIs parent company announced that KCI, LifeCell and Sytagenix would operate under one global medical technology brand known as Acelity. Acelity was acquired by Apax partners for 6.3B in 2011.

Key Metrics
  • Indian entity revenue
    ₹136 Cr

    FY 2025 · +148% YoY

  • Indian entity net profit
    ₹23.13 Cr

    FY 2025 · 17% margin

  • Indian entity EBITDA
    ₹20.47 Cr

    FY 2025 · 15% margin

  • Latest Funding Round
    $1.64B (USD), Debt – Conventional

    Feb 2017

  • Investors
    3M

    & 2 more

  • Investments & Acquisitions
  • Acquired by
    3M

    & 1 more

    (May 2019)

Funding Insights of Acelity

  • Total Rounds 2
  • Last Round Debt – Conventional — $1.64B
  • Investors Count 1

All 2 funding rounds of Acelity with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2017$1.64BDebt – Conventional––
–
Jun 2011Private Equity Round––
Valuation history

3 investors in total: 3 institutional.

Investors in Acelity

Acelity has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include 3M, Apax Partners and CPP Investments.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Equity investments are focused on tech, services, and consumer sectors.
1981apax.comHong Kong, China
Pension fund assets are managed for sustainable long-term growth.
1997cppinvestments.comToronto, Canada
3M is recognized as a global leader in industrial innovation.
19023m.comUnited States
Premium access

Investor details for Acelity

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Kci Medical India Private Limited (Acelity)

Kci Medical India Private Limited is the primary company behind Acelity. The board of Kci Medical India Private Limited currently have 3 directors; the longest-serving is Kuppanda Ayappa Appiah, appointed in 2019. 16 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kuppanda Ayappa Appiah
DIN 07939378
Director14 Oct 20197 yrsKci Medical India Private Limited
Inavolu Venkata Jagadish
DIN 10198591
Director03 Apr 20242 yrs 7 moKci Medical India Private Limited
Raj Kumar Khemani
DIN 09682850
Whole-time director29 Sep 20251 yr 1 moKci Medical India Private Limited

People of Acelity

818 people are tracked at Acelity (231 in leadership, 11 in board & advisors, 576 in team).

NameRoleGroup
Aparna Sardar
Country Head- Human Resources - IndiaLeadership
Mark Murphy
EVP & Chief Information & Digital OfficerLeadership
Delony Langer-Anderson
Technical Director Disruptive Technology And Sustainable MaterialsLeadership
Yolanda O'Brien
HR Services And Transformation Vice PresidentLeadership
Melanie Olsen
Director, HR Mergers, Acquisitions & TransitionsLeadership
Doug Cowan
VP, Global Supply ChainLeadership
Srinath R Deshapande
Head - IT Infrastructure And Security - India RegionLeadership
Gabe Hart
Consulting Director Of Data Platform Engineering (via Wexford Consulting)Leadership
Corey Bohnert
Sales Director- US & CANLeadership
Bill Pettit
Global Business Director: Fall ProtectionLeadership
Kimberly Johnson
Director Global QualityLeadership
Jon Ruppel
Senior Vice President, Total Rewards And ServicesLeadership
Laura Gagnon
Director, Global Business Process OptimizationLeadership
Alisha Tack
Vice President Human Resources, Transportation & Electronics Business GroupLeadership
Anurag Maheshwari
Executive Vice President, Chief Financial OfficerLeadership
Janel Haider
Business Transformation And IT DirectorLeadership
David Dorgan
Vice President; Supplier Performance & ProductivityLeadership
Adam Brodd
Global Application Engineering DirectorLeadership
Qujie Sadlo
Finance Director, Global ProcurementLeadership
Lisa Black
Global Sales Incentive DirectorLeadership

798 more people are available in the full profile.

Premium access

Complete people profiles for Acelity

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Acelity

Figures of Kci Medical India Private Limited, the primary company behind Acelity, for FY 2025. Revenue was ₹136 Cr (+148% year on year). Net profit was ₹23.13 Cr (17% margin). EBITDA was ₹20.47 Cr (15% margin). Revenue has grown at a compounded annual rate of +53% over three years and +24% over five years.

  • ₹136 CrRevenue · FY 2025 · +148% YoY
  • ₹23.13 CrNet profit · 17% margin
  • ₹20.47 CrEBITDA · 15% margin
  • ₹4.00 CrPaid-up capital
  • +53%Revenue CAGR, 3 years
  • +24%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Kci Medical India Private Limited are on its company page.

Premium access

Detailed financial statements for Acelity

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Acelity

Acelity has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Crawford Healthcare and Systagenix.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Manufacturer of wound care products
crawfordhealthcare.comCheshire, United Kingdom1996Jun 2018••••
Advanced wound therapeutics and regenerative medicine products are developed.
systagenix.comHorley, United Kingdom2008Jul 2013$485M
Premium access

Complete acquisition details for Acelity

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Acelity

7 dated milestones of Acelity across 43 years, from founding to its latest funding, stage changes and deals.

  1. Founded Acelity is founded.
  2. Funding First funding round.
  3. Exit Acquired by Apax.
  4. Acquisition Acquires Systagenix.
  5. Funding Latest funding round, Debt – Conventional, of $1.6B.
  6. Acquisition Acquires Crawford Healthcare.
  7. Exit Acquired by 3M.

Web traffic of Acelity

Websites that share an audience with Acelity (acelity.com).

Similar websites

Websites whose visitors overlap most with Acelity. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lifecell.com
100%
View details
legacymedsearch.com
92%
#5,132,467View details
kcij.com
kcij.com
91%
–

Top companies in Diversified Medical Devices

3 companies that operate in the same segment as Acelity (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medical equipment for treating over 30 chronic diseases is developed.
1949Minneapolis, Minnesota, United StatesUSD 36.36 B95,000
Wide range of medical devices
1979Marlborough, Massachusetts, United StatesUSD 20.07 B53,000
Healthcare solutions are provided by Johnson & Johnson globally.
1886New Brunswick, New Jersey, United StatesUSD 94.18 B139,800
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Acelity

Premium access

Complete news archive for Acelity

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Acelity

Acelity was founded in 1976 and raised its 1st funding round 35 years after it was founded.

Acelity is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.

The primary company behind Acelity, Kci Medical India Private Limited, reported revenue of ₹136 Cr for FY 2025, up 148% year on year.

Acelity is a privately held globally diversified medical device company. It is a non-operating holding company whose wholly owned subsidiaries develop wound therapeutics and regenerative medicine products. The advanced wound therapeutics business is conducted by Kinetic Concepts and its subsidiaries, including Systagenix, and the regenerative medicine business is conducted by LifeCell. Acelitys products are sold in over 80 countries. Its Advanced wound therapeutics unit produces products including negative pressure wound therapy, negative pressure surgical incision management, and epidermal harvesting. Its Regenerative medicine unit produces products encompassing regenerative and reconstructive acellular tissue matrices for repair of soft tissue defects, as well as autologous fat grafting solutions. Acelity began as Kinetic Concepts Inc., a medical technology company founded in 1976. In October 2013, KCI acquired Systagenix Wound Management, originally Johnson Johnsons professional wound care business for 485 million. In September 2014, KCIs parent company announced that KCI, LifeCell and Sytagenix would operate under one global medical technology brand known as Acelity. Acelity was acquired by Apax partners for 6.3B in 2011.

Acelity has made 2 acquisitions, including Crawford Healthcare, and Systagenix.

Acelity has 3 investors. Key investors include 3M, Apax Partners, and CPP Investments.

Acelity operates through Kci Medical India Private Limited.

Yes. Acelity was acquired by 3M in May 2019.

The legal entities of Acelity currently have 3 directors, including Raj Kumar Khemani, Inavolu Venkata Jagadish, Kuppanda Ayappa Appiah.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available